Synthesis and Assessment of Biological Activity of Quinazolinone-4(3H)-one Derivatives as Potential Anticancer Agents

Authors

  • Baljeet Singh Research Scholar, IKG Punjab Technical University, Kapurthala, Punjab, India
  • Shailesh Sharma Department of Pharmaceutical Sciences, ASBASJSM College of Pharmacy, Bela, Punjab, India
  • Manish Sinha Scientific Officer, Government Drug Testing Laboratory, Department of AYUSH, Gwalior, Madhya Pradesh, India
  • S. Sagar Scientist, Skanda Life Sciences Pvt Ltd, R and D Center, Bengaluru, Karnataka, India

Keywords:

Anticancer agents, Breast cancer, cell lines, MCF-7, Quinazolinone-4(3H)-one

Abstract

One of the foremost causes of death around world is cancer. Hence, there is a continuous research going on to find newer anticancer agents with least side effect. Quinazolinone is a privileged framework with prominent anticancer activities. A sequence of eight derivatives (5a-5h) of quinazolinone-4(3H)-one was prepared and tested for activity as anticancer agents against MCF-7 cell lines in this study. One of the compounds 5e showed good activity with 63.71% inhibition of cell growth as compared to 86.96% inhibition by standard doxorubicin.

Downloads

Download data is not yet available.

Downloads

Published

2021-10-09

How to Cite

Baljeet Singh, Shailesh Sharma, Manish Sinha, & S. Sagar. (2021). Synthesis and Assessment of Biological Activity of Quinazolinone-4(3H)-one Derivatives as Potential Anticancer Agents. Asian Pacific Journal of Health Sciences, 8(4), 214–220. Retrieved from https://apjhs.com/index.php/apjhs/article/view/1624